HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN"EN
11.7.2012 Official
Journal
of
the
European
Union L
179/3
COMMISSION REGULATION (EU) No 618/2012
of 10 July 2012
amending, for the purposes of its adaptation to technical and scientific progress, Regulation (EC) No
1272/2008 of the European Parliament and of the Council on classification, labelling and packaging
of substances and mixtures
(Text with EEA relevance)
THE EUROPEAN COMMISSION,
tration obligations resulting from the new harmonised
classifications for substances classified as carcinogenic,
mutagenic or toxic to reproduction, categories 1A and
Having regard to the Treaty on the Functioning of the European
1B (Table 3.1) and categories 1 and 2 (Table 3.2), or as
Union,
very toxic to aquatic organisms which may cause long
term effects in the aquatic environment, in particular
Having regard to Regulation (EC) No 1272/2008 of the
with those set out in Article 23 of Regulation (EC) No
European Parliament and of the Council of 16 December
1907/2006 of the European Parliament and of the
2008 on classification, labelling and packaging of substances
Council of 18 December 2006 concerning the Regis
and mixtures, amending and repealing Directives 67/548/EEC
tration, Evaluation, Authorisation and Restriction of
and 1999/45/EC, and amending Regulation (EC) No
Chemicals (REACH), establishing a European Chemicals
1907/2006 (
Agency, amending Directive 1999/45/EC and repealing

1 ), and in particular Article 37(5) thereof,
Council Regulation (EEC) No 793/93 and Commission
Regulation (EC) No 1488/94 as well as Council
Whereas:
Directive 76/769/EEC and Commission Directives
91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC ( 3 ).
(1) Part
3
of
Annex
VI
to
Regulation
(EC)
No
1272/2008
contains two lists of harmonised classification and
labelling of hazardous substances. Table 3.1 lists the
(4) In
line
with
the
transitional
provisions
of
Regulation
(EC)
No 1272/2008 which allow the application of the new
harmonised classification and labelling of hazardous
provisions at an earlier stage on a voluntary basis,
substances based on the criteria set out in Parts 2 to 5
suppliers should have the possibility of applying the
of Annex I to Regulation (EC) No 1272/2008. Table 3.2
harmonised classifications set out in Part 3 of Annex
lists the harmonised classification and labelling of
VI to Regulation (EC) No 1272/2008, as amended by
hazardous substances based on the criteria set out in
this Regulation, and of adapting the labelling and
Annex VI to Council Directive 67/548/EEC of 27 June
packaging accordingly on a voluntary basis before
1967 on the approximation of laws, regulations and
1 December 2013.
administrative provisions relating to the classification,

packaging and labelling of dangerous substances ( 2 ).
Those two lists need to be amended to include updated
classifications for substances already subject to those
(5) The
measures
provided
for
in
this
Regulation
are
in
harmonised classifications and to include new
accordance with the opinion of the Committee estab
harmonised classifications.
lished under Article 133 of Regulation (EC) No

1907/2006,
(2) The
Committee
for
Risk
Assessment
of
the
European
Chemicals Agency (ECHA) has issued opinions on
HAS ADOPTED THIS REGULATION:
proposals for harmonised classification and labelling of
substances which had been submitted to ECHA pursuant
to Article 37 of Regulation (EC) No 1272/2008. Based
Article 1
on those opinions, as well as on the comments received
Part 3 of Annex VI to Regulation (EC) No 1272/2008 is
from the parties concerned, it is appropriate to amend
amended as follows:
Annex VI to Regulation (EC) No 1272/2008 in order to
harmonise the classification and labelling of certain
substances.
(1) Table 3.1 is amended as follows:
(3) The
harmonised
classifications
set
out
in
Part
3
of
Annex
VI to Regulation (EC) No 1272/2008, as amended by this
(a) The entries corresponding to the entries set out in
Regulation, should not apply immediately, as a certain
Annex I are replaced by the entries set out in that
period of time will be necessary to allow operators to
Annex;
adapt the labelling and packaging of substances and
mixtures to the new classifications and to sell existing
stocks. In addition, a certain period of time will be
(b) The entries set out in Annex II are inserted in
necessary to allow operators to comply with the regis
accordance with the order of the entries set out in
Table 3.1.
( 1 ) OJ L 353, 31.12.2008, p. 1.
( 2 ) OJ 196, 16.8.1967, p. 1.
( 3 ) OJ L 136, 29.5.2007, p. 3.

---

L 179/4
EN
Official Journal of the European Union
11.7.2012
(2) Table 3.2 is amended as follows:
Article 2
This Regulation shall enter into force on the twentieth day
(a) The entries corresponding to the entries set out in
following that of its publication in the Official Journal of the
Annex III are replaced by the entries set out in that
European Union.
Annex;
Article 1 shall apply from 1 December 2013.
(b) The entries set out in Annex IV are inserted in
The harmonised classifications set out in Part 3 of Annex VI to
accordance with the order of the entries set out in
Regulation (EC) No 1272/2008, as amended by this Regulation,
Table 3.2.
may be applied before 1 December 2013.
This Regulation shall be binding in its entirety and directly applicable in all Member States.
Done at Brussels, 10 July 2012.
For the Commission
The President
José Manuel BARROSO

---

11.7.2012 Off
ANNEX I
Classification Labelling
Index No International
Chemical
Identification EC
No CAS
No
Specific Conc. Limits,
Hazard
Pictogram,
Hazard statement Suppl. Hazard
M-factors
Notes
Hazard Class and
Category Code(s)
Statement
Signal Word
statement
Code(s)
Code(s)
Code(s)
Code(s)
EN

"009-016-00-2 trisodium
hexafluoroaluminate
[1] 237-410-6
[1] 13775-53-6
[1] STOT
RE
1
H372
GHS07
H372
trisodium hexafluoroaluminate
239-148-8 [2] 15096-52-3
[2] Acute Tox. 4
H332
GHS08
H332
(cryolite) [2]
Aquatic
H411
GHS09
H411
Chronic 2
Dgr
603-012-00-X 2-ethoxyethanol;
203-804-1 110-80-5 Flam.
Liq.
3
H226
GHS02
H226
ethylene glycol monoethyl ether
Repr. 1B
H360FD
GHS08
H360FD
Acute Tox. 3
H331
GHS06
H331
Acute Tox. 4
H302
Dgr
H302
603-025-00-0 tetrahydrofuran 203-726-8 109-99-9 Flam.
Liq.
2
H225
GHS02
H225
EUH019 STOT
SE
3;
icial
Carc. 2
H351
GHS07
H351
H335: C ≥ 25 %
Jour
Eye Irrit. 2
H319
GHS08
H319
Eye Irrit.2;
STOT SE 3
H335
Dgr
H335
H319: C ≥ 25 %
nal
of
613-016-00-3 fuberidazole
(ISO);
223-404-0 3878-19-1 Carc.
2
H351
GHS07
H351
M = 1
the
2-(2-furyl)-1H-benzimidazole
Acute Tox. 4
H302
GHS08
H302
STOT RE 2
H373 (heart) GHS09
H373 (heart)
European
Skin Sens. 1
H317
Wng
H317
Aquatic Acute 1 H400
H410
Aquatic
H410
Union
Chronic 1
617-001-00-2 di-tert-butyl peroxide 203-733-6 110-05-4 Org.
Perox.
E
H242
GHS02
H242
Flam. Liq. 2
H225
GHS08
H225
Muta. 2
H341
Dgr
H341"
L
179/5

---

L 179/6
ANNEX II
Classification Labelling
Index No International
Chemical
Identification EC
No CAS
No
Suppl.
Specific Conc.
Hazard Statement
Pictogram, Signal
Hazard statement
Hazard
Limits, M-factors
Notes
Hazard Class and
Category Code(s)
Code(s)
Word Code(s)
Code(s)
statement
EN
Code(s)

‘015-199-00-X tris[2-chloro-1-chloromethyl)ethyl] 237-159-2 13674-87-8 Carc.
2 H351 GSH08 H351
phosphate
Wng
015-200-00-3 indium
phosphide 244-959-5 22398-80-7 Carc.
1B
H350
GHS08
H350
STOT RE 1;
Repr. 2
H361f
Dgr
H361f
H372: C ≥0,1 %
STOT RE 1
H372 (lungs)
H372 (lungs)
Carc 1B;
H350: C ≥0,01 %
Off
STOT RE 2;
H373: 0,01 % ≤
icial
C < 0,1 %
Jour
nal
015-201-00-9 trixylyl
phosphate 246-677-8 25155-23-1 Repr.
1B H360F GHS08 H360F
of
Dgr
the
European
015-202-00-4 tris(nonylphenyl)
phosphite 247-759-6 26523-78-4 Skin
Sens.
1 H317
GHS07
H317
Aquatic Acute 1
H400
GHS09
H410
Aquatic Chronic 1 H410
Wng
Union
015-203-00-X diphenyl(2,4,6-
278-355-8 75980-60-8 Repr.
2 H361f
(causing
GHS08
H361f (causing
trimethylbenzoyl)phosphine oxide
atrophy of the
Wng
atrophy of the
testes)
testes)
602-109-00-4 Hexabromocyclododecane
[1] 247-148-4
[1] 25637-99-4[1] Repr.
2
H361
GHS08
H361
Lact.
H362
Wng
H362
1,2,5,6,9,10-
221-695-9[2] 3194-55-6[2]
hexabromocyclododecane [2]
606-143-00-0 abamectin
(combination
of
_ [1] 71751-41-2
[1] Repr.
2
H361d
GHS06
H361d
STOT RE 1;
avermectin B1a and avermectin
Acute Tox. 2
H300
GHS08
H300
H372: C ≥ 5 %
B1b) (ISO) [1]
Acute Tox. 1
H330
GHS09
H330
STOT RE 2;
STOT RE 1
H372 (nervous Dgr
H372 (nervous
H373: 0,5 %
avermectin B1a (purity ≥80 %); [2] 265-610-3
[2] 65195-55-3
[2]
11.7.2012
Aquatic Acute 1
system)
system)
≤C<5 %
Aquatic Chronic 1 H400
H410
M = 10 000
H410

---

11.7.2012 Off
Classification Labelling
Index No International
Chemical
Identification EC
No CAS
No
Suppl.
Specific Conc.
Hazard Statement
Pictogram, Signal
Hazard statement
Hazard
Limits, M-factors
Notes
Hazard Class and
Category Code(s)
Code(s)
Word Code(s)
Code(s)
statement
Code(s)
606-144-00-6 acequinocyl
(ISO);
— 57960-19-7 Skin
Sens.
1 H317
GHS07
H317
M = 1 000
EN
3-dodecyl-1,4-dioxo-1,4-
STOT SE 1
H370 (lung)
GHS08
H370 (lung)

dihydronaphthalen-2-yl acetate
STOT RE 2
(inhalation)
GHS09
(inhalation)
Aquatic Acute 1
H373 (blood
Dgr
H373 (blood
Aquatic Chronic 1 system)
system)
H400
H410
H410
607-698-00-1 4-tert-butylbenzoic acid 202-696-3 98-73-7 Repr.
1B H360F
GHS07
H360F
STOT RE 1
H372
GHS08
H372
Acute Tox. 4
H302
Dgr
H302
612-281-00-2 leucomalachite
green;
204-961-9 129-73-7 Carc.
2
H351
GHS08
H351
icial
N,N,N',N'-tetramethyl-4,4'-
Muta. 2
H341
Wng
H341
benzylidenedianiline
Jour
nal
616-205-00-9 Metazachlor
(ISO);
266-583-0 67129-08-2 Skin
Sens.
1B H317
GHS07
H317
M = 100
of
2-chloro-N-(2,6-dimethylphenyl)-
Carc. 2
H351
GHS08
H351
M = 100’
the
N-(1H-pyrazol-1-
Aquatic Acute 1
H400
GHS09
H410
ylmethyl)acetamide
Aquatic Chronic 1 H410
Wng
European
Union
L
179/7

---

L 179/8
ANNEX III
Index No International
Chemical
Identification EC
No CAS
No Classification Labelling Concentration
Limits Notes
"009-016-00-2 trisodium
hexafluoroaluminate
[1] 237-410-6
[1] 13775-53-6
[1] Xn;
R20
T; N
trisodium hexafluoroaluminate (cryolite) [2] 239-148-8
[2] 15096-52-3
[2] T; R48/23/25
R: 20-48/23/25-51/53
N; R51-53
S: (1/2-)22-37-45-61
EN

603-012-00-X 2-ethoxyethanol;
203-804-1 110-80-5 R10
T
E
ethylene glycol monoethyl ether
Repr. Cat. 2; R60-61 R: 60-61-10-20/22
Xn; R20/22
S: 53-45
603-025-00-0 tetrahydrofuran 203-726-8 109-99-9 F;
R11-19
F; Xn
Xi; R36/37: C ≥ 25 %
Carc. Cat. 3; R40
R: 11-19-40-36/37
Xi; R36/37
S: (2-)(13-)16-29-33-36-37(-46)
613-016-00-3 fuberidazole
(ISO);
223-404-0 3878-19-1 Carc.
Cat.
3;
R40 Xn; N
N; R50-53: C ≥ 25 %
Off
2-(2-furyl)-1H-benzimidazole
Xn; R48/22
R: 40-48/22-22-43-50/53
N; R51-53: 2,5 % ≤ C < 25 %
Xn; R22
S: (2)-22-36/37-60-61
R52-53: 0,25 % ≤ C < 2,5 %
icial
Xi; R43
Jour
N; R50-53
nal
617-001-00-2 di-tert-butyl peroxide 203-733-6 110-05-4 O;
R7
O; F; Xn
of
F; R11
R: 7-11-68
the
Muta. Cat. 3, R68
S: (2-)3/7-14-16-23-36/37/39"
European
Union
11.7.2012

---

11.7.2012 Off
ANNEX IV
Index No International
Chemical
Identification EC
No CAS
No Classification Labelling Concentration
Limits Notes
‘015-199-00-X tris[2-chloro-1-chloromethyl)ethyl]
phosphate 237-159-2 13674-87-8 Carc.
Cat.
3;
R40 Xn
R: 40
S: (2-)36/37
EN

015-200-00-3 indium
phosphide 244-959-5 22398-80-7 Carc.
Cat.
2;
R45
T
T; R48/23: C ≥0,1%
E
Repr. Cat. 3; R62
R: 45–48/23–62
Carc Cat 2; R45:
T; R48/23
S: 45- 53
C ≥0,01%
Xn; R48/20: 0,01%≤
C < 0,1%
015-201-00-9 trixylyl
phosphate 246-677-8 25155-23-1 Repr.
Cat.
2;
R60 T
R: 60
S: 53-45
icial
015-202-00-4 tris(nonylphenyl)
phosphite 247-759-6 26523-78-4 Xi;
R43
Xi; N
Jour
N; R50-53
R: 43-50/53
S: 24-37-60-61
nal
of
the
015-203-00-X diphenyl(2,4,6-trimethylbenzoyl)phosphine
oxide 278-355-8 75980-60-8 Repr.
Cat.
3;
R62 Xn
R: 62
European
S: (2)-22-36/37.
602-109-00-4 Hexabromocyclododecane
[1] 247-148-4
[1] 25637-99-4[1] Repr.
Cat.
3;
R63 Xn
Union
1,2,5,6,9,10-hexabromocyclododecane [2] 221-695-9[2] 3194-55-6[2]
R64
R: 63-64
S: 36/37-53
606-143-00-0 abamectin
(combination
of
avermectin
B1a
and
_ [1] 71751-41-2
[1] Repr.
Cat.
3;
R63 T+; N
T; R48/23: C ≥ 5%
avermectin B1b) (ISO) [1]
T+; R26/28
R: 63-26/28-48/23/25-50/53 Xn; R48/20: 0,5% ≤ C <5%
avermectin B1a (purity ≥80%); [2] 265-610-3
[2] 65195-55-3
[2] T; R48/23/25
S: 28-36/37-45-60-61
N; R50-53: C ≥ 0,0025%
N; R50-53
N; R51-53: 0,00025% ≤
C <0,0025%
R52-53:
0,000025% ≤ C<0,00025%
606-144-00-6 acequinocyl
(ISO);
— 57960-19-7 T;
R39/23
T; N
N; R50-53: C ≥ 0,025%
3-dodecyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl acetate
Xi; R43
R: 39/23-43-50/53,
N; R51-53: 0,0025% ≤
N; R50-53
S: (2-)24-37-38-60-61
C < 0,025%
R52-53: 0,00025% ≤
C < 0,0025%
607-698-00-1 4-tert-butylbenzoic acid 202-696-3 98-73-7 Repr.
Cat.
2;
R60
T
E
L
T; R48/23/24/25
R: 60-22-48/23/24/25
179/9
Xn; R22
S: 53-45

---

L 179/10
Index No International
Chemical
Identification EC
No CAS
No Classification Labelling Concentration
Limits Notes
612-281-00-2 leucomalachite
green
204-961-9 129-73-7 Carc.
Cat.
3;
R40
Xn
N,N,N',N'-tetramethyl-4,4'-benzylidenedianiline
Muta. Cat. 3; R68
R: 40-68
S: (2-)36/37
616-205-00-9 Metazachlor
(ISO);
266-583-0 67129-08-2 R43
Xn; N
N; R50-53: C ≥ 0,25%
2-chloro-N-(2,6-dimethylphenyl)-N-(1H-pyrazol-1-
Carc. Cat. 3; R40
R: 40-43-50/53
N; R51-53: 0,025% ≤
EN
ylmethyl)acetamide
N; R50-53
S: (2-)36-37-60-61
C < 0,25%

R52-53: 0,0025% ≤
C < 0,025%’
Off
icial
Jour
nal
of
the
European
Union
11.7.2012

---

Document Outline

• �

---